既往SARS-CoV-2感染与冠状动脉微血管功能障碍的关联:一项初步研究
该单中心初步研究纳入35例COVID-19感染前后均接受临床指征PET/CT的患者,并与70例年龄、性别及心血管危险因素2:1匹配的COVID-19阴性历史对照比较。以MFR<2定义CMD,主要终点为全局MFR变化(ΔMFR)。结果显示两组全局ΔMFR无显著差异(0.07 vs -0.10,P=0.23),多数参与者CMD状态不变(COVID-19组83%,对照组60%),提示轻度COVID-19感染未导致PET/CT可检测的持续性冠状动脉微血管功能障碍。
要点
- 既往轻度COVID-19感染后中位2.8年,全局MFR变化与匹配对照无显著差异。
- 多数患者CMD状态未改变,COVID-19组83%、对照组60%。
- 研究提示轻度COVID-19感染不造成PET/CT可检出的持续性CMD。
核心结论
- 尽管既往有证据提示COVID-19与CMD相关,但康复的COVID-19感染患者MFR和CMD状态无 apparent 纵向变化。
- 研究提示轻度COVID-19感染不导致PET/CT可检测的持续性冠状动脉微血管功能障碍。
研究设计与样本
- 单中心研究纳入35例在COVID-19感染前后均接受临床指征心脏PET/CT的患者。
- 与70例COVID-19阴性历史对照按年龄、性别及心血管危险因素2:1匹配。
- 以MFR<2定义CMD,主要终点为全局MFR变化(ΔMFR=随访-基线)。
- 采用线性回归和条件logistic回归校正匹配依赖性。
主要发现
- COVID-19患者两次PET/CT检查的中位间隔为2.8年。
- 大多数患者症状轻微,94%已免疫接种。
- 基线灌注异常两组相似(13% vs 29%,P=0.05)。
- COVID-19组与对照组全局ΔMFR无显著差异(0.07 vs -0.10,P=0.23)。
- 多数参与者CMD状态不变(COVID-19组83%,对照组60%)。
关键数值与推荐
- MFR小于2用于定义CMD。
临床怎么用
- 对于轻度COVID-19感染康复患者,PET/CT检测的MFR和CMD状态在纵向随访中未见明显改变。
- 临床解读COVID-19后心脏PET/CT时,不应默认存在持续性冠状动脉微血管功能障碍。
局限性
- 本研究为单中心初步研究,样本量较小(COVID-19组35例,对照组70例)。
- 大多数患者症状轻微且94%已免疫接种,结论可能不适用于重症或未免疫人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular complications from coronavirus disease 2019 (COVID-19) contribute to its morbidity. COVID-19 has been associated with coronary microvascular dysfunction (CMD), yet the long-term relationship is not well understood. We aimed to assess changes in CMD status and myocardial flow reserve (MFR among patients with prior COVID-19 infection using serial cardiac PET/CT imaging. METHODS: single-center study of 35 patients who underwent clinically indicated PET/CT before and after COVID-19 infection. They were compared with 70 historical COVID-19-negative controls matched 2:1 for age and sex, and cardiovascular risk factors. MFR less than 2 was used to define CMD. The primary outcome was the change in global MFR (ΔMFR = follow-up-baseline). Linear and conditional logistic regression were used to account for matching dependencies. RESULTS: The median interval between PET/CT studies among COVID-19 patients was 2.8 years. Most patients had mild symptoms, and 94% were immunized. Baseline perfusion abnormalities were similar between groups (13% vs 29%, P = 0.05). There was no significant difference in global ΔMFR between COVID-19 and control groups (0.07 vs -0.10, P = 0.23). CMD status remained unchanged among most participants (83% in the COVID-19 group and 60% in controls). CONCLUSIONS: Despite prior evidence of an association between COVID-19 and CMD, there were no apparent longitudinal changes in MFR and CMD status in patients with recovered COVID-19 infection. These findings suggest that mild COVID-19 infection does not confer persistent coronary microvascular dysfunction detectable by PET/CT.
引用
- Kounga C, Huck D, Sun A, et al. Association of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronary microvascular dysfunction: A pilot study. J Nucl Cardiol. 2026. PMID: 41759765. doi:10.1016/j.nuclcard.2026.102675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。